IP Library Granted Patent US 12,290,612
Granted Patent B2
US 12,290,612 · App. 16/989,307 · Granted May 6, 2025

Aligned fiber and method of use thereof

Inventors: Michael Francis (Virginia Beach, VA); Roy Ogle (Virginia Beach, VA)
Assignee: LifeNet Health
A61L27/18A61L27/24A61L27/26A61L27/3604A61L27/3633A61L27/38A61L27/383A61L27/56C12N5/0618D01D5/0076D01D5/0092A61F2/08A61F2240/001A61L2400/12C12N2533/30C12N2533/54C12N2533/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,290,612
App. No.
16/989,307
Granted
May 6, 2025
Kind
B2
Abstract

A scaffold comprising an aligned fiber. Further, a scaffold comprising one or more electrospun fibers wherein a fast Fourier transform (FFT) analysis result of the fibers have adjacent major peaks with about 180° apart from each other. Also, methods for promoting differentiation of stem cells into osteoblasts, chondrocytes, ligament or tendon, the method comprising culturing the cells on the scaffold or aligned fiber in conditions suitable for the cell differentiation.

Claims (28)

1. A composite scaffold comprising:

multiple layers of sheets including at least a first layer and a second layer, wherein

the first layer comprises electrospun fibers comprising collagen and a copolymer, wherein a result of a fast Fourier transform (FFT) analysis demonstrates that the first layer fibers are aligned having major adjacent peaks that are about 180° apart from each other, and

the second layer comprises random fibers.

2. The composite scaffold according to claim 1 , wherein the scaffold is in a form of one or more elongated sheets.

3. The composite scaffold according to claim 2 , wherein the first layer fibers are aligned on the scaffold in a direction parallel to a length of the one or more elongated sheets.

4. The composite scaffold according to claim 1 , wherein the scaffold is in a form of one or more elongated rolls.

5. The composite scaffold according to claim 3 , wherein the first layer fibers are aligned on the scaffold in a direction parallel to a length of the one or more elongated rolls.

6. The composite scaffold according to claim 1 , wherein the scaffold has an average porosity from about 60% to about 95%.

7. The composite scaffold according to claim 1 , wherein the scaffold has an average porosity from about 70% to about 90%.

8. The composite scaffold according to claim 1 , wherein the scaffold comprises an extracellular matrix component.

9. The composite scaffold according to claim 8 , wherein the extracellular matrix component is selected from the group consisting of collagen, glycosaminoglycans, osteocalcin, osteonectin, bone sialo protein, osteopontin, fibronectin, laminin, and mixtures thereof.

10. The composite scaffold of claim 1 , further comprising cells selected from the group consisting of stem cells, adipose derived stem cells, dental pulp stem cells, fibroblasts, and dorsal root ganglia.

11. The composite scaffold according to claim 1 , wherein the scaffold is biocompatible.

12. The composite scaffold according to claim 1 , wherein materials for the first layer fibers and the second layer fibers are different from each other.

13. The composite scaffold according to claim 1 , wherein the first layer fibers and the second layer fibers have different fiber diameters.

14. The composite scaffold according to claim 1 , wherein materials for the first layer fibers and the second layer fibers are the same.

15. The composite scaffold according to claim 1 , wherein the first layer fibers have an average diameter from about 5 nm to about 1000 nm.

16. The composite scaffold according to claim 1 , wherein the first layer fibers have an average diameter of 600 nm or less.

17. The composite scaffold according to claim 1 , wherein the first layer fibers have an average diameter of 300 nm or less.

18. The composite scaffold according to claim 1 , wherein the first layer fibers have an average diameter of 500 nm or more.

19. The composite scaffold according to claim 1 , wherein the first layer fibers have an average diameter of 100 nm or more.

20. The composite scaffold according to claim 1 , wherein the first layer fibers are aligned on the scaffold in a parallel direction.

21. The composite scaffold according to claim 1 , wherein the first layer fibers have an average diameter of 1000 nm or more.

22. The composite scaffold according to claim 1 , wherein the copolymer is selected from the group consisting of polycaprolactone, poly (glycolic acid), poly (lactic acid), polydioxanone, poly (lactide-co-glycolide) copolymers, polyesters, polysaccharides, polyhydroxyalka noates, starch, polylactic acid, cellulose, proteins, agar, silks, alginate, collagen/gelatin, carrageenan, elastin, pectin, resilin, konjac, adhesives, gums, polyamino acids, polysaccharides, soy, zein, wheat gluten, casein, chitin/chitosan, serum albumin, hyaluronic acid, lipids/surfactants, xanthan, acetoglycerides, waxes, surfactants, dextran, emulsan, gelian, polyphenols, levan, lignin, curd, ian, tannin, polygalactosamine, humic acid, shellac, pullulan, poly-gamma-glutamic acid, elsinan, natural rubber, yeast glucans, synthetic polymers from natural fats and oils.

23. The composite scaffold according to claim 1 , wherein the copolymer comprises polylactic acid.

24. The composite scaffold according to claim 1 , wherein the collagen comprises bovine collagen.

25. The composite scaffold according to claim 1 , wherein the collagen in the first layer fibers is not chemically cross-linked.

Assignments (2)
SECURITY INTEREST Recorded Apr 2, 2021
From: LIFENET HEALTH; SKIN AND WOUND ALLOGRAFT INSTITUTE, LLC
To: TRUIST BANK
Reel/Frame 055815/0623 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2020
From: FRANCIS, MICHAEL; OGLE, ROY
To: LIFENET HEALTH
Reel/Frame 053455/0193 →